201 related articles for article (PubMed ID: 17911479)
1. Mechanism of action of IFN-beta in the treatment of multiple sclerosis: a special reference to CD73 and adenosine.
Airas L; Niemelä J; Yegutkin G; Jalkanen S
Ann N Y Acad Sci; 2007 Sep; 1110():641-8. PubMed ID: 17911479
[TBL] [Abstract][Full Text] [Related]
2. IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier.
Niemelä J; Ifergan I; Yegutkin GG; Jalkanen S; Prat A; Airas L
Eur J Immunol; 2008 Oct; 38(10):2718-26. PubMed ID: 18825744
[TBL] [Abstract][Full Text] [Related]
3. IFN-beta protects from vascular leakage via up-regulation of CD73.
Kiss J; Yegutkin GG; Koskinen K; Savunen T; Jalkanen S; Salmi M
Eur J Immunol; 2007 Dec; 37(12):3334-8. PubMed ID: 18034430
[TBL] [Abstract][Full Text] [Related]
4. IFN-alpha induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-5'-nucleotidase) up-regulation.
Niemelä J; Henttinen T; Yegutkin GG; Airas L; Kujari AM; Rajala P; Jalkanen S
J Immunol; 2004 Feb; 172(3):1646-53. PubMed ID: 14734746
[TBL] [Abstract][Full Text] [Related]
5. Nucleoside-5'-monophosphates as prodrugs of adenosine A2A receptor agonists activated by ecto-5'-nucleotidase.
El-Tayeb A; Iqbal J; Behrenswerth A; Romio M; Schneider M; Zimmermann H; Schrader J; Müller CE
J Med Chem; 2009 Dec; 52(23):7669-77. PubMed ID: 19580286
[TBL] [Abstract][Full Text] [Related]
6. Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis.
Biernacki K; Antel JP; Blain M; Narayanan S; Arnold DL; Prat A
Arch Neurol; 2005 Apr; 62(4):563-8. PubMed ID: 15824253
[TBL] [Abstract][Full Text] [Related]
7. Activity and expression of ecto-5'-nucleotidase/CD73 are increased during phenotype conversion of a hepatic stellate cell line.
Andrade CM; Roesch GC; Wink MR; Guimarães EL; Souza LF; Jardim FR; Guaragna RM; Bernard EA; Margis R; Borojevic R; Battastini AM; Guma FC
Life Sci; 2008 Jan; 82(1-2):21-9. PubMed ID: 18037449
[TBL] [Abstract][Full Text] [Related]
8. Protective role of ecto-5'-nucleotidase (CD73) in renal ischemia.
Grenz A; Zhang H; Eckle T; Mittelbronn M; Wehrmann M; Köhle C; Kloor D; Thompson LF; Osswald H; Eltzschig HK
J Am Soc Nephrol; 2007 Mar; 18(3):833-45. PubMed ID: 17267736
[TBL] [Abstract][Full Text] [Related]
9. The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study.
Bellingan G; Maksimow M; Howell DC; Stotz M; Beale R; Beatty M; Walsh T; Binning A; Davidson A; Kuper M; Shah S; Cooper J; Waris M; Yegutkin GG; Jalkanen J; Salmi M; Piippo I; Jalkanen M; Montgomery H; Jalkanen S
Lancet Respir Med; 2014 Feb; 2(2):98-107. PubMed ID: 24503265
[TBL] [Abstract][Full Text] [Related]
10. Extracellular adenosine production by ecto-5'-nucleotidase protects during murine hepatic ischemic preconditioning.
Hart ML; Much C; Gorzolla IC; Schittenhelm J; Kloor D; Stahl GL; Eltzschig HK
Gastroenterology; 2008 Nov; 135(5):1739-1750.e3. PubMed ID: 18804111
[TBL] [Abstract][Full Text] [Related]
11. The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5'-nucleotidase: findings in a study of ecto-5'-nucleotidase gene-deficient mice.
Montesinos MC; Takedachi M; Thompson LF; Wilder TF; Fernández P; Cronstein BN
Arthritis Rheum; 2007 May; 56(5):1440-5. PubMed ID: 17469101
[TBL] [Abstract][Full Text] [Related]
12. Interferon-beta therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism.
Azoulay D; Mausner-Fainberg K; Urshansky N; Fahoum F; Karni A
J Neuroimmunol; 2009 Jun; 211(1-2):114-9. PubMed ID: 19419774
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effect of interferon-beta treatment in patients with multiple sclerosis is associated with transient increase in serum IL-6 level in response to interferon-beta injection.
Nakatsuji Y; Nakano M; Moriya M; Kishigami H; Tatsumi C; Tada S; Sadahiro S; Naka T; Mitani K; Funauchi M; Azuma T; Watanabe S; Kinoshita M; Kajiyama K; Yuasa Y; Kaido M; Takahashi MP; Naba I; Hazama T; Sakoda S;
Cytokine; 2006 Oct; 36(1-2):69-74. PubMed ID: 17161613
[TBL] [Abstract][Full Text] [Related]
14. Genomic effects of once-weekly, intramuscular interferon-beta1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patients.
Weinstock-Guttman B; Bhasi K; Badgett D; Tamaño-Blanco M; Minhas M; Feichter J; Patrick K; Munschauer F; Bakshi R; Ramanathan M
J Neuroimmunol; 2008 Dec; 205(1-2):113-25. PubMed ID: 18950872
[TBL] [Abstract][Full Text] [Related]
15. No correlation between CD73 expression and ecto-5'-nucleotidase activity on blood mononuclear cells in vitro. Evidence of CD73 (ecto-5'-nucleotidase) on blood mononuclear cells with distinct antigenic properties.
Christensen LD
APMIS; 1996 Feb; 104(2):126-34. PubMed ID: 8619914
[TBL] [Abstract][Full Text] [Related]
16. CD73 is expressed on invading T lymphocytes in the inflamed peripheral nerve.
Meyer Zu Hörste G; Reiners J; Lehmann HC; Airas L; Kieseier BC
Muscle Nerve; 2009 Aug; 40(2):287-9. PubMed ID: 19609917
[TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP in rat ileum: evidence for the presence of an extracellular cyclic AMP-adenosine pathway.
Giron MC; Bin A; Brun P; Etteri S; Bolego C; Florio C; Gaion RM
Gastroenterology; 2008 Apr; 134(4):1116-26. PubMed ID: 18316082
[TBL] [Abstract][Full Text] [Related]
18. Time-course changes in ectonucleotidase activities during experimental autoimmune encephalomyelitis.
Lavrnja I; Bjelobaba I; Stojiljkovic M; Pekovic S; Mostarica-Stojkovic M; Stosic-Grujicic S; Nedeljkovic N
Neurochem Int; 2009 Sep; 55(4):193-8. PubMed ID: 19524108
[TBL] [Abstract][Full Text] [Related]
19. Expression of Th1 and Th17 cytokines and transcription factors in multiple sclerosis patients: does baseline T-bet mRNA predict the response to interferon-beta treatment?
Drulovic J; Savic E; Pekmezovic T; Mesaros S; Stojsavljevic N; Dujmovic-Basuroski I; Kostic J; Vasic V; Mostarica Stojkovic M; Popadic D
J Neuroimmunol; 2009 Oct; 215(1-2):90-5. PubMed ID: 19695714
[TBL] [Abstract][Full Text] [Related]
20. Potential for interferon beta-induced serum antibodies in multiple sclerosis to inhibit endogenous interferon-regulated chemokine/cytokine responses within the central nervous system.
Shapiro AM; Jack CS; Lapierre Y; Arbour N; Bar-Or A; Antel JP
Arch Neurol; 2006 Sep; 63(9):1296-9. PubMed ID: 16966508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
